RO118174B1 - Lac de unghii şi utilizarea acestuia - Google Patents

Lac de unghii şi utilizarea acestuia

Info

Publication number
RO118174B1
RO118174B1 RO98-01261A RO9801261A RO118174B1 RO 118174 B1 RO118174 B1 RO 118174B1 RO 9801261 A RO9801261 A RO 9801261A RO 118174 B1 RO118174 B1 RO 118174B1
Authority
RO
Romania
Prior art keywords
nail polish
weight
nail
psoriasis
physiollogically
Prior art date
Application number
RO98-01261A
Other languages
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of RO118174B1 publication Critical patent/RO118174B1/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Invenţia se referă la un lac de unghii şi la utilizarea acestuia, în domeniul medical, pentru tratamentul psoriazisului, la unghiile de la mâini şi picioare. Lacul de unghii, conform invenţiei, conţine 0,5...20% în greutate un glucocorticoid ca substanţă activă, 20...75% în greutate din cel puţin un solvent compatibil fiziologic şi 4...75% în greutate din cel puţin un formator de peliculă, insolubil în apă, şi este utilizat pentru tratamentul psoriazisului unghiilor.
RO98-01261A 1997-08-21 1998-08-05 Lac de unghii şi utilizarea acestuia RO118174B1 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19736112 1997-08-21

Publications (1)

Publication Number Publication Date
RO118174B1 true RO118174B1 (ro) 2003-03-28

Family

ID=7839551

Family Applications (1)

Application Number Title Priority Date Filing Date
RO98-01261A RO118174B1 (ro) 1997-08-21 1998-08-05 Lac de unghii şi utilizarea acestuia

Country Status (35)

Country Link
US (3) US6352686B2 (ro)
EP (1) EP0913154B1 (ro)
JP (1) JPH11130679A (ro)
KR (1) KR100610517B1 (ro)
CN (1) CN1155386C (ro)
AR (1) AR015933A1 (ro)
AT (1) ATE227993T1 (ro)
AU (1) AU740615B2 (ro)
BG (1) BG63270B1 (ro)
BR (1) BR9803756A (ro)
CA (1) CA2245637C (ro)
CO (1) CO4960649A1 (ro)
CZ (1) CZ292344B6 (ro)
DE (1) DE59806343D1 (ro)
DK (1) DK0913154T3 (ro)
ES (1) ES2186952T3 (ro)
HR (1) HRP980458B1 (ro)
HU (1) HUP9801898A3 (ro)
ID (1) ID20731A (ro)
IL (1) IL125854A (ro)
MY (1) MY128558A (ro)
NO (1) NO319391B1 (ro)
NZ (1) NZ331443A (ro)
PL (1) PL192342B1 (ro)
PT (1) PT913154E (ro)
RO (1) RO118174B1 (ro)
RU (1) RU2210354C2 (ro)
SG (1) SG68072A1 (ro)
SI (1) SI0913154T1 (ro)
SK (1) SK284218B6 (ro)
TR (1) TR199801609A2 (ro)
TW (1) TW590776B (ro)
UA (1) UA51693C2 (ro)
YU (1) YU49492B (ro)
ZA (1) ZA987531B (ro)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
AU2002248308B2 (en) * 2001-01-09 2006-12-07 Israel Dvoretzky Therapeutic film forming composition and treatment system
FR2830449B1 (fr) * 2001-10-05 2004-04-23 Fabre Pierre Dermo Cosmetique Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
FR2835180B1 (fr) * 2002-01-30 2004-04-09 Fiabila Vernis a ongles multiphase
AU2002950506A0 (en) * 2002-07-31 2002-09-12 Soltec Research Pty Ltd Percutaneous delivery system
EP1854466A1 (en) * 2002-12-17 2007-11-14 Galderma Research & Development, S.N.C. Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
FR2848454B1 (fr) * 2002-12-17 2007-03-30 Galderma Res & Dev Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide
MXPA05003805A (es) * 2002-12-17 2005-06-08 Galderma Sa Composiciones farmaceuticas que comprenden una combinacion de calcitriol y propionato de clobetasol.
US7238533B1 (en) * 2003-07-22 2007-07-03 Ronald Legge Personal illicit drug detection method
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
JP4608618B2 (ja) * 2004-07-02 2011-01-12 有限会社 エヌ・ピィ・アール ネイルアート用溶液
US20060062982A1 (en) * 2004-09-17 2006-03-23 Massachusetts Institute Of Technology Carbon-polymer electrochemical systems and methods of fabricating them using layer-by-layer technology
CA2498623A1 (en) * 2005-02-18 2006-08-18 Qlt Inc. Treatment of onychomycosis
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
EP1874320A1 (en) * 2005-04-19 2008-01-09 Galderma S.A. Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology
CA2609579C (en) * 2005-05-27 2014-08-19 Taro Pharmaceuticals North America, Inc. Stable liquid desoximetasone compositions with reduced oxidized impurity
KR100803926B1 (ko) 2006-07-27 2008-02-15 주식회사 코리아나화장품 샌드프리 화장료 조성물
US20090317341A1 (en) * 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
DK3403654T3 (da) 2009-10-01 2019-08-26 Adare Dev I L P Oralt administrerede kortikosteroidsammensætninger
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
PL233616B1 (pl) 2017-08-10 2019-11-29 Podopharm Spolka Z Ograniczona Odpowiedzialnoscia Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu
US20250332120A1 (en) * 2022-07-28 2025-10-30 Kao Corporation Composition for external preparation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928261A (en) * 1973-05-17 1975-12-23 Minnesota Mining & Mfg Water removable film-forming compositions for topical application to skin
US3861932A (en) * 1973-12-13 1975-01-21 Revlon Stabilization of nitrocellulose
US3966924A (en) * 1974-11-13 1976-06-29 Allergan Pharmaceuticals Composition and method for treating psoriasis
US4179304A (en) * 1978-04-03 1979-12-18 Polychrome Corporation Finger nail lacquer
US4210633A (en) * 1978-10-20 1980-07-01 Eli Lilly And Company Flurandrenolide film formulation
US4250164A (en) * 1979-04-09 1981-02-10 Bernstein Joel E Method of treating psoriasis of the nails and composition
JPH01501143A (ja) * 1985-11-04 1989-04-20 ダ−マトロジカル・プロダクツ・オブ・テキサス 爪への薬物の施用のための皮膜形成性製剤用ヴェヒクル、これらのヴェヒクルを基にした薬剤組成物および同じものの使用法
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3612305A1 (de) * 1986-04-11 1987-10-22 Roehm Pharma Gmbh Fluessige arzneiform zur therapie der psoriasis auf basis filmbildender polymere
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
US5093108A (en) * 1989-02-16 1992-03-03 Amalia, Inc. Quick-drying nail enamel compositions and method for coating a surface
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5258186A (en) * 1989-03-10 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Drug release controlling coating material for long acting formulations
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE19518262A1 (de) * 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
EP0711181A1 (en) * 1993-07-28 1996-05-15 Pfizer Inc. Psoriasis treatment
DK128494A (da) * 1994-11-08 1996-05-09 Edel K Seidenschnur Behandling af keratinøse og psoriatiske sygdomstilstande med neglelak indeholdende vitamin D metabolit, eller derivat, og/eller vitamin A derivat
DE19529085A1 (de) * 1995-08-08 1997-02-13 Christiane Dr Med Wurdel Nagellack zur Bekämpfung der Schuppenflechte im Nagelbereich
BR9708081A (pt) * 1996-03-16 1999-07-27 Hoechst Ag Formulações tópicas para tratamento de psóriase de unhas
GB9609653D0 (en) 1996-05-09 1996-07-10 Applied Research Ars Holding N Method of assay
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia

Also Published As

Publication number Publication date
HRP980458B1 (en) 2002-12-31
TR199801609A3 (tr) 1999-03-22
BG63270B1 (bg) 2001-08-31
EP0913154A1 (de) 1999-05-06
CN1155386C (zh) 2004-06-30
CZ292344B6 (cs) 2003-09-17
JPH11130679A (ja) 1999-05-18
TW590776B (en) 2004-06-11
HUP9801898A3 (en) 2000-01-28
CZ263298A3 (cs) 1999-03-17
NO983818L (no) 1999-02-22
TR199801609A2 (xx) 1999-03-22
PL192342B1 (pl) 2006-10-31
AR015933A1 (es) 2001-05-30
NO983818D0 (no) 1998-08-20
US6352686B2 (en) 2002-03-05
PL328122A1 (en) 1999-03-01
NO319391B1 (no) 2005-08-08
DK0913154T3 (da) 2003-03-03
SG68072A1 (en) 1999-10-19
PT913154E (pt) 2003-04-30
MY128558A (en) 2007-02-28
DE59806343D1 (de) 2003-01-02
RU2210354C2 (ru) 2003-08-20
HUP9801898A1 (hu) 1999-04-28
KR19990023719A (ko) 1999-03-25
SI0913154T1 (en) 2003-04-30
US20020071815A1 (en) 2002-06-13
KR100610517B1 (ko) 2007-04-25
SK284218B6 (en) 2004-11-03
HRP980458A2 (en) 1999-06-30
AU740615B2 (en) 2001-11-08
YU49492B (sh) 2006-08-17
BR9803756A (pt) 2000-03-28
HU9801898D0 (en) 1998-10-28
IL125854A0 (en) 1999-04-11
BG102696A (en) 1999-04-30
CN1209318A (zh) 1999-03-03
CA2245637A1 (en) 1999-02-21
ID20731A (id) 1999-02-25
US20010006625A1 (en) 2001-07-05
ZA987531B (en) 1999-02-22
US20040071645A1 (en) 2004-04-15
EP0913154B1 (de) 2002-11-20
SK114398A3 (en) 1999-03-12
IL125854A (en) 2004-02-19
NZ331443A (en) 1999-01-28
YU34998A (sh) 2002-11-15
UA51693C2 (uk) 2002-12-16
CA2245637C (en) 2008-07-15
HK1018214A1 (en) 1999-12-17
CO4960649A1 (es) 2000-09-25
ES2186952T3 (es) 2003-05-16
ATE227993T1 (de) 2002-12-15
AU8085698A (en) 1999-03-04

Similar Documents

Publication Publication Date Title
RO118174B1 (ro) Lac de unghii şi utilizarea acestuia
ATE290401T1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
ATE214933T1 (de) Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
EP0852949A3 (en) Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation
ATE258426T1 (de) Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen
WO2002030367A8 (en) Scalp cosmetic and dermatological compositions
GEP20022786B (en) Purine Inhibitors of Cyclin Dependent Kinase 2 and 1kB-a
FR2782269B1 (fr) Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
CA2243566A1 (en) Anti-fungal nail lacquer and method therefor
CA2404810A1 (en) Topical composition having undifferentiated plant seed cells and method for using same
US5853768A (en) Topical preparation and method for pain relief
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
AU2108500A (en) Galenic formulation containing biotin
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
FR2761885B1 (fr) Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique
MY124480A (en) Use of glyceryl triacetate for treating onychomycoses
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
FR2753371B1 (fr) Utilisation d'un extrait de la plante terminalia catappa et compositions cosmetique dermatologique et pharmaceutique comportant un tel extrait
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
UY26514A1 (es) " composición para el tratamiento de tejidos danados".
IE810489L (en) Composition for topical application
EP0244937A3 (en) Pharmaceutical compositions containing (R,S) or (S) N-(2-[2-hydroxy-3-phenoxypropyl]aminoethyl)isobutyramide
BR9709989A (pt) Processos para tratamento de uma doenca de planta, para preparacão de uma substância ou composicão para tratamento de doenca de planta e para fertilizacão de uma planta, para fertilizacao de uma planta, substâncias ou composicões para tratamento de uma doenca de planta e para fertilizacão de uma planta, e, uso das mesmas.
BG105924A (en) Composition for the treatment of psoriasis